Trial
NCT05502783
Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborators
—
Condition
Immune Mediated Anemia
Intervention
fostamatinib
Why stopped
Clinical trial was halted prematurely due to low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-05